| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |